Paloma Partners Management CO Amphastar Pharmaceuticals, Inc. Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $224,812 - $265,965	-11,758 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $122,469 - $148,620	-6,473 Reduced 35.51%	11,758 $248,000
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $354,775 - $460,879	18,231 New	18,231 $373,000
Q4 2018 Feb 14, 2019	SELL	$17.72 - $22.51 $205,552 - $261,116	-11,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $178,524 - $224,808	11,600 New	11,600 $223,000
Q1 2018 May 15, 2018	SELL	$17.23 - $20.35 $176,797 - $208,811	-10,261 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.76 - $19.75 $182,235 - $202,654	10,261	10,261 $197,000

286

35.1M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.19B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.